The effects of flaxseed (Linum usitatissimum) supplementation on anthropometric indices: An updated systematic review and meta-analysis of randomized clinical trials DOI Creative Commons
Vali Musazadeh,

MohammadReza Abolghasemian,

Zeynab Kavyani

и другие.

Complementary Therapies in Medicine, Год журнала: 2024, Номер 84, С. 103066 - 103066

Опубликована: Июль 9, 2024

Flaxseed (Linum usitatissimum) supplementation has shown promise as an anti-obesity agent in various clinical trials, although results have been inconsistent. To provide a more accurate assessment of the impact flaxseed on anthropometric indices, systematic review and meta-analysis was performed.

Язык: Английский

Trends in insulin resistance: insights into mechanisms and therapeutic strategy DOI Creative Commons

Mengwei Li,

Xiaowei Chi, Ying Wang

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2022, Номер 7(1)

Опубликована: Июль 6, 2022

The centenary of insulin discovery represents an important opportunity to transform diabetes from a fatal diagnosis into medically manageable chronic condition. Insulin is key peptide hormone and mediates the systemic glucose metabolism in different tissues. resistance (IR) disordered biological response for stimulation through disruption molecular pathways target Acquired conditions genetic factors have been implicated IR. Recent biochemical studies suggest that dysregulated metabolic mediators released by adipose tissue including adipokines, cytokines, chemokines, excess lipids toxic lipid metabolites promote IR other associated with several groups abnormal syndromes include obesity, diabetes, dysfunction-associated fatty liver disease (MAFLD), cardiovascular disease, polycystic ovary syndrome (PCOS), abnormalities. Although no medication specifically approved treat IR, we summarized lifestyle changes pharmacological medications used as efficient intervention improve sensitivity. Ultimately, systematic discussion complex mechanism will help identify potential new targets closely

Язык: Английский

Процитировано

439

Increased cell senescence in human metabolic disorders DOI Creative Commons
Rosa Spinelli,

Ritesh K. Baboota,

Silvia Gogg

и другие.

Journal of Clinical Investigation, Год журнала: 2023, Номер 133(12)

Опубликована: Июнь 14, 2023

Cell senescence (CS) is at the nexus between aging and associated chronic disorders, increases burden of CS in all major metabolic tissues. However, also increased adult obesity, type 2 diabetes (T2D), nonalcoholic fatty liver disease independent aging. Senescent tissues are characterized by dysfunctional cells inflammation, both progenitor mature, fully differentiated nonproliferating afflicted. Recent studies have shown that hyperinsulinemia insulin resistance (IR) promote human adipose cells. Similarly, promotes cellular IR, showing their interdependence. Furthermore, T2D age, BMI, degree hyperinsulinemia, suggesting premature These results suggest senomorphic/senolytic therapy may become important for treating these common disorders.

Язык: Английский

Процитировано

47

Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity DOI Creative Commons
Max C. Petersen, Gordon I. Smith, Hector H. Palacios

и другие.

Cell Metabolism, Год журнала: 2024, Номер 36(4), С. 745 - 761.e5

Опубликована: Апрель 1, 2024

There is considerable heterogeneity in the cardiometabolic abnormalities associated with obesity. We evaluated multi-organ system metabolic function 20 adults metabolically healthy obesity (MHO; normal fasting glucose and triglycerides, oral tolerance, intrahepatic triglyceride content, whole-body insulin sensitivity), unhealthy (MUO; prediabetes, hepatic steatosis, resistance), 15 who were lean. Compared MUO, people MHO had (1) altered skeletal muscle biology (decreased ceramide content increased expression of genes involved BCAA catabolism mitochondrial structure/function); (2) adipose tissue inflammation extracellular matrix remodeling lipogenesis); (3) lower 24-h plasma glucose, insulin, non-esterified fatty acids, triglycerides; (4) higher adiponectin PAI-1 concentrations; (5) decreased oxidative stress. These findings provide a framework potential mechanisms responsible for This study was registered at ClinicalTrials.gov (NCT02706262).

Язык: Английский

Процитировано

38

The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreaticβ-Cell Function and Diabetes DOI Creative Commons
Matthew J. Varney, Jeffrey Benovic

Pharmacological Reviews, Год журнала: 2024, Номер 76(2), С. 267 - 299

Опубликована: Янв. 30, 2024

Type 2 diabetes mellitus (T2D) has emerged as a major global health concern that accelerated in recent years due to poor diet and lifestyle. Afflicted individuals have high blood glucose levels stem from the inability of pancreas make enough insulin meet demand. While medication can help maintain normal with chronic disease, many these medicines are outdated, severe side effects, often become less efficacious over time necessitating need for therapy. G protein-coupled receptors (GPCRs) regulate physiological processes including levels. In pancreatic β-cells, GPCRs β-cell growth, apoptosis, secretion which all critical maintaining sufficient mass output ensure euglycemia. years, new insight into signaling incretin other underscored potential desirable targets treatment diabetes. The is modulated by GPCR kinases (GRKs) phosphorylate agonist activated marking receptor arrestin binding internalization. Interestingly, genome wide association studies (GWAS) using diabetic patient cohorts link GRKs arrestins T2D. Moreover, reports show expressed serve role regulation function growth both dependent independent pathways. this review, we describe importance GRK modulating physiology. Significance Statement Pancreatic β-cells contain diverse array been shown improve survival, yet only handful successfully targeted This review discusses advances our understanding pharmacology while also highlighting necessity investigating islet enriched largely unexplored unveil novel strategies.

Язык: Английский

Процитировано

21

Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases DOI Open Access
Gerhard P. Püschel,

Julia Klauder,

J Henkel

и другие.

Journal of Clinical Medicine, Год журнала: 2022, Номер 11(15), С. 4358 - 4358

Опубликована: Июль 27, 2022

Metabolic derangement with poor glycemic control accompanying overweight and obesity is associated chronic low-grade inflammation hyperinsulinemia. Macrophages, which present a very heterogeneous population of cells, play key role in the maintenance normal tissue homeostasis, but functional alterations resident macrophage pool as well newly recruited monocyte-derived macrophages are important drivers development inflammation. While metabolic dysfunction, insulin resistance damage may trigger or advance pro-inflammatory responses macrophages, itself contributes to resulting Macrophages express receptors whose downstream signaling networks share number knots pathways pattern recognition cytokine receptors, shape polarity. The shared allow enhance attenuate both anti-inflammatory responses. This supposedly physiological function be impaired by hyperinsulinemia macrophages. review discusses mutual ambiguous relationship inflammation, resistance, insulin-dependent modulation activity focus on adipose liver.

Язык: Английский

Процитировано

71

Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies DOI Creative Commons
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya

и другие.

Biomedicines, Год журнала: 2023, Номер 11(4), С. 1126 - 1126

Опубликована: Апрель 7, 2023

Diabetes mellitus (DM) and cardiovascular complications are two unmet medical emergencies that can occur together. The rising incidence of heart failure in diabetic populations, addition to apparent coronary disease, ischemia, hypertension-related complications, has created a more challenging situation. Diabetes, as predominant cardio-renal metabolic syndrome, is related severe vascular risk factors, it underlies various complex pathophysiological pathways at the molecular level progress converge toward development cardiomyopathy (DCM). DCM involves several downstream cascades cause structural functional alterations heart, such diastolic dysfunction progressing into systolic dysfunction, cardiomyocyte hypertrophy, myocardial fibrosis, subsequent over time. effects glucagon-like peptide-1 (GLP-1) analogues sodium-glucose cotransporter-2 (SGLT-2) inhibitors on (CV) outcomes diabetes have shown promising results, including improved contractile bioenergetics significant benefits. purpose this article highlight pathophysiological, metabolic, contribute its cardiac morphology functioning. Additionally, will discuss potential therapies may be available future.

Язык: Английский

Процитировано

31

Glucokinase activity in diabetes: too much of a good thing? DOI Creative Commons
Frances M. Ashcroft, Matthew Lloyd, Elizabeth Haythorne

и другие.

Trends in Endocrinology and Metabolism, Год журнала: 2022, Номер 34(2), С. 119 - 130

Опубликована: Дек. 29, 2022

Type 2 diabetes (T2D) is a global health problem characterised by chronic hyperglycaemia due to inadequate insulin secretion. Because glucose must be metabolised stimulate release it was initially argued that drugs glucokinase (the first enzyme in metabolism) would enhance secretion diabetes. However, the long term, activators have been largely disappointing. Recent studies show hyperactivation of metabolism, not itself, underlies progressive decline beta-cell function This perspective discusses if exacerbate this (by promoting and, counterintuitively, inhibitors might better therapeutic strategy for preserving T2D.

Язык: Английский

Процитировано

34

Precision nutrition in diabetes: when population-based dietary advice gets personal DOI Open Access
Jordi Merino

Diabetologia, Год журнала: 2022, Номер 65(11), С. 1839 - 1848

Опубликована: Май 20, 2022

Язык: Английский

Процитировано

30

Endocrine disruptors in plastics alter β-cell physiology and increase the risk of diabetes mellitus DOI Creative Commons
Juan Martínez‐Pinna, Roberto Sempere-Navarro, Regla M. Medina-Gali

и другие.

AJP Endocrinology and Metabolism, Год журнала: 2023, Номер 324(6), С. E488 - E505

Опубликована: Май 3, 2023

Plastic pollution breaks a planetary boundary threatening wildlife and humans through its physical chemical effects. Of the latter, release of endocrine disrupting chemicals (EDCs) has consequences on prevalence human diseases related to system. Bisphenols (BPs) phthalates are two groups EDCs commonly found in plastics that migrate into environment make low-dose exposure ubiquitous. Here we review epidemiological, animal, cellular studies linking BPs altered glucose regulation, with emphasis role pancreatic β-cells. Epidemiological indicate is associated diabetes mellitus. Studies animal models treatment doses within range decreases insulin sensitivity tolerance, induces dyslipidemia, modifies functional β-cell mass serum levels insulin, leptin, adiponectin. These reveal disruption physiology by plays key impairing homeostasis altering mechanisms used β-cells adapt metabolic stress such as chronic nutrient excess. at level demonstrate modify same biochemical pathways involved adaptation excess fuel. include changes biosynthesis secretion, electrical activity, expression genes, mitochondrial function. The data summarized here important risk factors for mellitus support global effort decrease plastic EDCs.

Язык: Английский

Процитировано

20

Low and high carbohydrate isocaloric diets on performance, fat oxidation, glucose and cardiometabolic health in middle age males DOI Creative Commons
Philip J. Prins, Timothy D. Noakes, Alex Buga

и другие.

Frontiers in Nutrition, Год журнала: 2023, Номер 10

Опубликована: Фев. 9, 2023

High carbohydrate, low fat (HCLF) diets have been the predominant nutrition strategy for athletic performance, but recent evidence following multi-week habituation has challenged superiority of HCLF over high (LCHF) diets, along with growing interest in potential health and disease implications dietary choice. Highly trained competitive middle-aged athletes underwent two 31-day isocaloric (HCLF or LCHF) a randomized, counterbalanced, crossover design while controlling calories training load. Performance, body composition, substrate oxidation, cardiometabolic, minute-by-minute glucose (CGM) biomarkers were assessed. We demonstrated: (i) equivalent high-intensity performance (@∼85%VO 2max ), fasting insulin, hsCRP, HbA 1c without significant composition changes across groups; (ii) record peak oxidation rates (LCHF:1.58 ± 0.33g/min @ 86.40 6.24%VO ; 30% subjects > 1.85 g/min); (iii) higher total, LDL, HDL cholesterol on LCHF; (iv) reduced mean/median variability LCHF. also found that mean predicted reductions LCHF, reduction LCHF rates. Interestingly, had mean, median 100 mg/dL (range: 111.68-115.19 mg/dL; consistent pre-diabetes), largest glycemic response to carbohydrate restriction. These results: challenge whether intake is superior even during shorter-duration, higher-intensity exercise; demonstrate lower may be therapeutic independently improve control, particularly those at risk diabetes; unique relationship between continuous parameters systemic metabolism.

Язык: Английский

Процитировано

16